{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:54:11Z","timestamp":1784555651591,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC112-2314-B-038-100-MY3 -"],"award-info":[{"award-number":["NSTC112-2314-B-038-100-MY3 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC112-2314-B-038-065"],"award-info":[{"award-number":["NSTC112-2314-B-038-065"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018493","name":"Taipei Medical University Shuang Ho Hospital","doi-asserted-by":"publisher","award":["112TMU-SHH-03"],"award-info":[{"award-number":["112TMU-SHH-03"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bbadis.2024.167106","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T06:28:58Z","timestamp":1709188138000},"page":"167106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and enhances immunotherapeutic sensitivity"],"prefix":"10.1016","volume":"1870","author":[{"given":"Kuan-Chou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trayee","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Chang-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Chi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167106_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2024.167106_bb0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/iju.15263","article-title":"Recent advancements in the diagnosis and treatment of non-muscle invasive bladder cancer: evidence update of surgical concept, risk stratification, and BCG-treated disease","volume":"30","author":"Miyake","year":"2023","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109821","article-title":"Cancer immunotherapy: pros, cons and beyond","volume":"124","author":"Tan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2024.167106_bb0020","article-title":"Role of immunotherapy in bladder cancer","volume":"26","author":"Rhea","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.bbadis.2024.167106_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12943-018-0864-3","article-title":"Biomarkers for predicting efficacy of PD-1\/PD-L1 inhibitors","volume":"17","author":"Yi","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2024.167106_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166016","article-title":"Cancer cell metabolism: rewiring the mitochondrial hub","volume":"1867","author":"Oliveira","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2024.167106_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","article-title":"Cancer cells don\u2019t live alone: metabolic communication within tumor microenvironments","volume":"54","author":"Li","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbadis.2024.167106_bb0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2024.167106_bb0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.phrs.2016.10.027","article-title":"NAD(+) salvage pathway in cancer metabolism and therapy","volume":"114","author":"Kennedy","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2024.167106_bb0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","article-title":"The NAD(+)\/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling","volume":"154","author":"Mouchiroud","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167106_bb0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/bies.10297","article-title":"Reconstructing eukaryotic NAD metabolism","volume":"25","author":"Rongvaux","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.bbadis.2024.167106_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2024.167106_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fonc.2020.00358","article-title":"NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation","volume":"10","author":"Audrito","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0075","first-page":"135","article-title":"Enzymology of NAD+ synthesis","volume":"73","author":"Magni","year":"1999","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and pathophysiological roles of NAMPT and NAD metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0085","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/bph.13505","article-title":"Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine","volume":"173","author":"Grolla","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0090","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1947601913507576","article-title":"Nicotinamide phosphoribosyltransferase in malignancy: a review","volume":"4","author":"Shackelford","year":"2013","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbadis.2024.167106_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092059","article-title":"Updated functional roles of NAMPT in carcinogenesis and therapeutic niches","volume":"14","author":"Lin","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2024.167106_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.970553","article-title":"Review of various NAMPT inhibitors for the treatment of cancer","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbadis.2024.167106_bb0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2020.10.021","article-title":"NAD(+) metabolism maintains inducible PD-L1 expression to drive tumor immune evasion","volume":"33","author":"Lv","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2024.167106_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2024.167106_bb0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac090","article-title":"cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines","volume":"23","author":"Cheng","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bbadis.2024.167106_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103059","article-title":"Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: novel biomarker and therapeutic target","volume":"61","author":"Sun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2024.167106_bb0135","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2024.167106_bb0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167106_bb0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","article-title":"TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells","volume":"21","author":"Ping","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2024.167106_bb0150","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1038\/s41467-019-11078-z","article-title":"Boosting NAD(+) with a small molecule that activates NAMPT","volume":"10","author":"Gardell","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2024.167106_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2024.167106_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109516","article-title":"NAD(+) supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells","volume":"36","author":"Wang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2024.167106_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymthe.2022.09.013","article-title":"NAMPT is a metabolic checkpoint of IFNgamma-producing CD4(+) T cells in lupus nephritis","volume":"31","author":"Li","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2024.167106_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010089","article-title":"The dark side of IFN-gamma: its role in promoting cancer immunoevasion","volume":"19","author":"Mojic","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2024.167106_bb0175","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3892\/ol.2020.11757","article-title":"Interferon-gamma induced PD-L1 expression and soluble PD-L1 production in gastric cancer","volume":"20","author":"Imai","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2024.167106_bb0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s13046-019-1403-9","article-title":"IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression","volume":"38","author":"Thiem","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167106_bb0185","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.molcel.2021.03.037","article-title":"Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade","volume":"81","author":"Dai","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2024.167106_bb0190","article-title":"EMA restricts use of anti-PD-1 drugs for bladder cancer","volume":"19","author":"Gourd","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106189","article-title":"NAMPT: a critical driver and therapeutic target for cancer","volume":"145","author":"Gasparrini","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0200","first-page":"327","article-title":"Metabolic changes in bladder cancer","volume":"36","author":"Woolbright","year":"2018","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.bbadis.2024.167106_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2018.05.006","article-title":"NAD metabolism: implications in aging and longevity","volume":"47","author":"Yaku","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2024.167106_bb0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3325\/cmj.2014.55.507","article-title":"Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer","volume":"55","author":"Zhang","year":"2014","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.bbadis.2024.167106_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.urology.2006.10.014","article-title":"Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract","volume":"69","author":"Kondo","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.bbadis.2024.167106_bb0220","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s13258-022-01318-w","article-title":"FK866 inhibits colorectal cancer metastasis by reducing NAD(+) levels in cancer-associated fibroblasts","volume":"44","author":"Xie","year":"2022","journal-title":"Genes Genomics"},{"key":"10.1016\/j.bbadis.2024.167106_bb0225","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.18632\/aging.102410","article-title":"Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc\/NAMPT\/SIRT1-dependent FOXO1 and YAP signaling","volume":"11","author":"Liu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2024.167106_bb0230","first-page":"6648","article-title":"Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis","volume":"15","author":"Zhou","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2024.167106_bb0235","first-page":"7231","article-title":"FK866 inhibits the epithelial-mesenchymal transition of hepatocarcinoma MHCC97-H cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2024.167106_bb0240","article-title":"Immunometabolism in the tumor microenvironment and its related research progress","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0245","doi-asserted-by":"crossref","first-page":"19352","DOI":"10.18632\/aging.203333","article-title":"Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database","volume":"13","author":"Guo","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2024.167106_bb0250","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12935-022-02664-1","article-title":"Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment","volume":"22","author":"Xu","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2024.167106_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1615\/CritRevImmunol.2016017387","article-title":"Metabolic regulation of natural killer cell IFN-gamma production","volume":"36","author":"Mah","year":"2016","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-pathol-031920-093932","article-title":"Opposing roles of type I interferons in cancer immunity","volume":"16","author":"Boukhaled","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbadis.2024.167106_bb0270","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2024.167106_bb0275","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4049\/jimmunol.1103227","article-title":"Innate IFN-\u03b3 is essential for programmed death ligand-1\u2013mediated T cell stimulation following Listeria monocytogenes infection","volume":"189","author":"Rowe","year":"2012","journal-title":"J. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:43:14Z","timestamp":1751215394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0925443924000954"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167106","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and enhances immunotherapeutic sensitivity","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167106"}}